Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 5 | 2022 | 73 | 1.010 |
Why?
|
| Esophagitis | 3 | 2008 | 202 | 0.600 |
Why?
|
| Esophagus | 4 | 2008 | 553 | 0.340 |
Why?
|
| Androstadienes | 1 | 2008 | 165 | 0.290 |
Why?
|
| Leukotrienes | 1 | 2006 | 14 | 0.280 |
Why?
|
| Prednisone | 1 | 2008 | 984 | 0.260 |
Why?
|
| Eosinophilia | 2 | 2022 | 176 | 0.240 |
Why?
|
| Gastritis | 2 | 2022 | 373 | 0.210 |
Why?
|
| Enteritis | 1 | 2022 | 65 | 0.200 |
Why?
|
| Biomarkers | 2 | 2018 | 5047 | 0.200 |
Why?
|
| Gastroesophageal Reflux | 2 | 2018 | 334 | 0.190 |
Why?
|
| Sucrase-Isomaltase Complex | 1 | 2020 | 31 | 0.190 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2020 | 45 | 0.180 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2018 | 5 | 0.170 |
Why?
|
| Proton Pump Inhibitors | 2 | 2018 | 249 | 0.170 |
Why?
|
| Eosinophils | 2 | 2011 | 162 | 0.150 |
Why?
|
| Gastroenterology | 1 | 2018 | 195 | 0.130 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2015 | 51 | 0.130 |
Why?
|
| Esophageal pH Monitoring | 2 | 2018 | 9 | 0.120 |
Why?
|
| Esophagoscopy | 3 | 2018 | 291 | 0.110 |
Why?
|
| Eosinophil-Derived Neurotoxin | 1 | 2011 | 8 | 0.110 |
Why?
|
| Child, Preschool | 6 | 2018 | 16273 | 0.100 |
Why?
|
| Interleukin-5 | 1 | 2011 | 73 | 0.100 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 295 | 0.100 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 248 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 2011 | 202 | 0.090 |
Why?
|
| Forecasting | 1 | 2013 | 694 | 0.090 |
Why?
|
| Child | 8 | 2020 | 29154 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2020 | 12873 | 0.090 |
Why?
|
| Fluticasone | 1 | 2008 | 23 | 0.080 |
Why?
|
| Mucous Membrane | 2 | 2006 | 271 | 0.080 |
Why?
|
| Telemetry | 1 | 2007 | 39 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2013 | 1145 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 3251 | 0.080 |
Why?
|
| Prevalence | 4 | 2020 | 3260 | 0.070 |
Why?
|
| Adolescent | 7 | 2020 | 31252 | 0.070 |
Why?
|
| Duodenitis | 1 | 2006 | 15 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1945 | 0.070 |
Why?
|
| Consensus | 2 | 2022 | 978 | 0.070 |
Why?
|
| Infant | 4 | 2018 | 13310 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 4367 | 0.070 |
Why?
|
| Mycoses | 1 | 2008 | 386 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2008 | 1544 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 4320 | 0.060 |
Why?
|
| Male | 10 | 2020 | 123000 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2006 | 527 | 0.060 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 353 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2013 | 6869 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2006 | 764 | 0.050 |
Why?
|
| Female | 10 | 2020 | 141928 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2011 | 6100 | 0.050 |
Why?
|
| Biopsy | 2 | 2006 | 3443 | 0.050 |
Why?
|
| Humans | 13 | 2022 | 261506 | 0.050 |
Why?
|
| Phenotype | 1 | 2011 | 6295 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 2195 | 0.040 |
Why?
|
| Recurrence | 1 | 2008 | 4758 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2018 | 135 | 0.040 |
Why?
|
| Manometry | 1 | 2018 | 74 | 0.040 |
Why?
|
| Antacids | 1 | 2018 | 29 | 0.040 |
Why?
|
| Fundoplication | 1 | 2018 | 56 | 0.040 |
Why?
|
| Nutritional Support | 1 | 2018 | 80 | 0.040 |
Why?
|
| Internationality | 1 | 2018 | 208 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2018 | 173 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 1020 | 0.040 |
Why?
|
| Complementary Therapies | 1 | 2018 | 126 | 0.040 |
Why?
|
| Reference Values | 1 | 2018 | 1099 | 0.040 |
Why?
|
| Physical Examination | 1 | 2018 | 299 | 0.030 |
Why?
|
| Bronchial Provocation Tests | 1 | 2015 | 18 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 375 | 0.030 |
Why?
|
| Breath Tests | 1 | 2015 | 177 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1363 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2015 | 684 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 4892 | 0.030 |
Why?
|
| Prognosis | 3 | 2018 | 21713 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 2218 | 0.030 |
Why?
|
| Patient Safety | 1 | 2018 | 649 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 2588 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 32848 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 3472 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 4109 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2015 | 644 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 4938 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 4744 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 4549 | 0.020 |
Why?
|
| Heartburn | 1 | 2007 | 19 | 0.020 |
Why?
|
| Monitoring, Ambulatory | 1 | 2007 | 63 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 7548 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 3890 | 0.020 |
Why?
|
| Cough | 1 | 2007 | 116 | 0.020 |
Why?
|
| Chest Pain | 1 | 2007 | 155 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8865 | 0.020 |
Why?
|
| Vomiting | 1 | 2007 | 354 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 4314 | 0.020 |
Why?
|
| Catheterization | 1 | 2007 | 410 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 341 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8223 | 0.020 |
Why?
|
| Dermatitis, Contact | 1 | 2004 | 34 | 0.020 |
Why?
|
| Lung | 1 | 2015 | 3151 | 0.020 |
Why?
|
| Triglycerides | 1 | 2006 | 603 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 585 | 0.010 |
Why?
|
| Risk Factors | 2 | 2013 | 17523 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 5673 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 915 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2004 | 216 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 502 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12221 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 4298 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 14889 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 5377 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 1054 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 6009 | 0.010 |
Why?
|
| Hypertension | 1 | 2006 | 1503 | 0.010 |
Why?
|
| United States | 1 | 2013 | 15433 | 0.010 |
Why?
|
| Middle Aged | 2 | 2013 | 86204 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 37905 | 0.010 |
Why?
|
| Aged | 1 | 2006 | 70117 | 0.000 |
Why?
|